Friday, October 20, 2017 10:42:16 AM
And pinning Salas as not being a closer isn't fair. Maybe the product isn't closable.
Garza himself should be out making sales. If the product is as good as hyped, he shouldn't have to put in 60 hours a week to close one good-sized contract. Hell, he's had quite a bit of time to just put in a few hours a day making calls, sending information out and meeting with companies in order to have one sale under his belt that would lead to others.
Maybe Garza is the one who should be replaced.
You can lead a horse to water. But you can't make him get down on one knee and do an Al Jolson impression!
Recent SDCH News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 09:54:48 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 09:48:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 12:00:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 01:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 12:05:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/07/2024 12:00:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 09:30:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 01:30:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 08:57:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 08:55:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 08:53:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 08:51:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 12:15:57 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/05/2024 01:00:19 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 12/28/2023 10:25:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 12/27/2023 10:00:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:00:16 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 12/21/2023 02:09:12 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 12/11/2023 10:01:10 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 12/04/2023 03:58:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 10:00:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:13:59 PM
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 11/03/2023 02:09:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 08:54:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 08:52:33 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM